Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA
Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC ( Prof Ahmed Kaseb - MD Anderson Cancer Center, Houston, USA )
4 Oct 2019
CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line...
Dr Thomas Yau - The University of Hong Kong, Hong Kong
CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line treatment in advanced hepatocellular carcinoma ( Dr Thomas Yau - The University of Hong Kong, Hong Kong )
4 Oct 2019
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer
Dr Parag Parikh - Mayo Clinic, Rochester, USA
Radiotherapy for liver cancer, and neoadjuvant therapy for rectal cancer ( Dr Parag Parikh - Mayo Clinic, Rochester, USA )
17 Jul 2019
Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Laparoscopic versus open resection for colorectal liver metastases ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
Managing metastatic breast cancer and beyond using PARP inhibitors
Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
Managing metastatic breast cancer and beyond using PARP inhibitors ( Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA )
11 Jun 2019
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherap...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Sp...
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019
Maintenance therapy with PARP inhibitor olaparib delays progression in patients ...
Dr Hedy Kindler - University of Chicago, Chicago, USA
Maintenance therapy with PARP inhibitor olaparib delays progression in patients with BRCA-related pancreatic cancer ( Dr Hedy Kindler - University of Chicago, Chicago, USA )
2 Jun 2019
Comment: It is essential to identify the BRCA gene in pancreatic cancer patients...
Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA
Comment: It is essential to identify the BRCA gene in pancreatic cancer patients allowing them to be treated with an oral agent ( Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA )
2 Jun 2019
B-lymphoid transcriptional programme as a barrier against malignant transformati...
Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA
B-lymphoid transcriptional programme as a barrier against malignant transformation in acute lymphoblastic leukaemia ( Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA )
24 May 2019
Emerging role of radioembolization for hepatocellular carcinoma
Prof Riad Salem - Northwestern University, Chicago, USA
Emerging role of radioembolization for hepatocellular carcinoma ( Prof Riad Salem - Northwestern University, Chicago, USA )
8 May 2019
Advanced HCC: New systemic treatment options
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
Surgical management of pancreatic cancer
Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia
Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )
8 May 2019